{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "24550227",
        "21670202",
        "22150006",
        "26200345",
        "22077063"
      ],
      "tumorType":{
        "children":{},
        "code":"CLLSLL",
        "color":"LimeGreen",
        "id":533,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "parent":"MBN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx2",
      "pmids":[
        "19794079",
        "16826225",
        "15472075",
        "16707600"
      ],
      "tumorType":{
        "children":{},
        "code":"",
        "color":"LimeGreen",
        "id":941,
        "level":0,
        "mainType":{
          "id":null,
          "name":"T-Lymphoblastic Leukemia/Lymphoma",
          "tumorForm":"LIQUID"
        },
        "name":"",
        "parent":null,
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"NOTCH1, a transmembrane receptor and transcription factor, can function as both an oncogene and tumor suppressor.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx2",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":"LEVEL_Px3",
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"04/13/2017",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "25806268",
        "22056382",
        "24651013",
        "16738328",
        "16618740"
      ]
    },
    "description":"The NOTCH1 I1616N mutation occurs within the NOTCH1 heterodimerization domain which is critical for assembly, stabilization and ligand-dependent activation of the NOTCH1 protein (PMID:24651013). Exogenous expression of the I1616N mutation, in the context of both full-length NOTCH1 as well as an \u0394EGF NOTCH1, results in increased NOTCH1 downstream transcriptional signaling when measured by a NOTCH1-responsive reporter (PMID: 16738328). In addition, this mutation resulted in increased ligand-independent S2 cleavage (PMID: 16738328). In addition, this mutation resulted in increased ligand-independent S2 cleavage (PMID: 16738328). Increased NOTCH1 expression and activity has been shown to upregulate a variety of known oncogenic pathways including PI3K, EGFR, NF-\u03baB; however the mechanism remains unclear and may prove to be cancer-type specific (PMID: 25806268, 22056382, 16618740).",
    "knownEffect":"Gain-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Px3",
      "pmids":[
        "20861909",
        "16707600",
        "20861920"
      ],
      "tumorType":{
        "children":{},
        "code":"",
        "color":"LimeGreen",
        "id":941,
        "level":0,
        "mainType":{
          "id":null,
          "name":"T-Lymphoblastic Leukemia/Lymphoma",
          "tumorForm":"LIQUID"
        },
        "name":"",
        "parent":null,
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "prognosticSummary":"",
  "query":{
    "alteration":"I1616N",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":4851,
    "hgvs":"9:g.136504844A>T",
    "hugoSymbol":"NOTCH1",
    "id":null,
    "proteinEnd":1616,
    "proteinStart":1616,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The NOTCH1 I1616N mutation is likely oncogenic.",
  "vus":false
}